Log In
BCIQ
Print this Print this
 

Qutenza, capsaicin (NGX-4010)

Also known as: formerly Transacin

  Manage Alerts
Collapse Summary General Information
Company Acorda Therapeutics Inc.
DescriptionDermal patch containing 8% capsaicin
Molecular Target Transient receptor potential vanilloid 1 (TRPV1) (VR1)
Mechanism of ActionTransient receptor potential vanilloid 1 (TRPV1) (VR1) agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$158.6M

$56.5M

$97.1M


 Deals Details
Get a free BioCentury trial today